Adult-Onset Asthma: Why Asthma Can Start at Any Age

Medically reviewed | Florida Asthma Clinic | Updated May 2026

Most people associate asthma with childhood — a condition diagnosed in young children and either managed through adolescence or quietly outgrown. That picture is only half the story. Asthma can develop for the first time in adults in their 20s, 40s, 50s and even 60s. When it does, it is frequently misidentified as a respiratory infection, heart disease or simply the inevitable slowing down of an aging body. The delay in diagnosis that follows can mean months or years of unnecessary breathlessness and reduced quality of life.

Understanding adult-onset asthma — what drives it, how it presents differently and how it is treated — is the first step toward getting an accurate diagnosis and effective relief.

What Is Adult-Onset Asthma?

Adult-onset asthma refers to asthma that is diagnosed for the first time in adulthood, typically after the age of 20. It involves the same underlying airway biology as classic asthma: chronic inflammation of the bronchial lining, reversible narrowing of the airways, and an increased sensitivity to certain triggers that causes episodes of breathlessness, wheezing, chest tightness and cough.

What makes it distinct is the context in which it develops. Adults who receive a new asthma diagnosis often have no family history of asthma, no childhood history of atopic conditions such as eczema or hay fever, and no obvious allergic trigger. Instead, their asthma is frequently linked to something that changed in their adult environment, their body or their health — a new job, a hormonal shift, significant weight gain or a severe respiratory infection.

Adult-onset asthma is more common than many people realise. Studies consistently show that approximately half of all new asthma diagnoses occur in adults, and the rate of adult diagnosis has increased over recent decades. Women are diagnosed with adult-onset asthma more often than men, a pattern that appears to be closely linked to hormonal factors.

Common Causes and Risk Factors

Unlike childhood asthma, which is predominantly allergic in nature, adult-onset asthma is often driven by non-allergic mechanisms. Several well-documented risk factors and causes have been identified.

Occupational Exposures

Occupational asthma is one of the most significant causes of new asthma in working-age adults, accounting for an estimated 15 to 25 percent of adult cases. More than 300 workplace substances have been identified as asthma-inducing agents. Among the most common are isocyanates (found in spray paints, polyurethane foams and adhesives), flour and grain dust (a major hazard for bakers and food processors), cleaning and disinfecting products, latex, animal allergens in laboratory and veterinary settings, and reactive dyes used in textile manufacture.

The pattern of occupational asthma is often a clue to the diagnosis: symptoms that improve on weekends or during vacations away from work, and return or worsen when back at work, should prompt a thorough occupational history. Early identification and removal from the offending exposure offers the best chance of long-term improvement.

Hormonal Changes

The female predominance of adult-onset asthma points strongly to hormonal influences. New asthma frequently appears around the time of menopause, when estrogen levels fall significantly. Conversely, some women develop asthma symptoms during or after pregnancy, or notice that asthma worsens at particular points in their menstrual cycle. Hormone replacement therapy has a complex relationship with asthma risk and should be discussed with a specialist if you have respiratory symptoms.

Obesity

Obesity is an independent risk factor for asthma in adults. Excess weight reduces lung volumes by placing mechanical pressure on the diaphragm and chest wall. Adipose tissue also releases pro-inflammatory cytokines that promote airway inflammation. Asthma in obese adults tends to be more difficult to control and less responsive to standard inhaled corticosteroid therapy. Even modest weight reduction can produce meaningful improvements in asthma control.

Smoking History and Respiratory Infections

While smoking does not directly cause asthma, it increases airway inflammation and reactivity, making the development of asthma more likely in susceptible individuals. Severe or recurrent respiratory infections — particularly viral infections such as influenza, respiratory syncytial virus (RSV) or rhinovirus — can trigger new-onset asthma or unmask latent airway hyper-responsiveness in adults who previously had no symptoms.

Aspirin and NSAID Sensitivity

Aspirin-exacerbated respiratory disease (AERD) is a specific adult-onset syndrome that combines asthma, chronic rhinosinusitis with nasal polyps, and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen. AERD affects approximately 10 percent of adult asthmatics. Reactions can be severe and rapid, making it essential that adults with asthma — particularly those with nasal polyps — inform all treating physicians of their diagnosis before any NSAID is prescribed.

Gastroesophageal Reflux Disease (GERD)

GERD is highly prevalent in adults with asthma, and the relationship runs in both directions: acid reflux can worsen asthma symptoms by triggering airway inflammation and bronchospasm via micro-aspiration or vagal nerve reflexes, while some asthma medications and the mechanics of labored breathing can worsen reflux. Treating GERD effectively can improve asthma control in some patients, though the benefit varies considerably from person to person.

How Adult-Onset Asthma Differs from Childhood Asthma

Understanding the differences between adult-onset and childhood asthma matters for both diagnosis and management.

Less likely to be allergic: Childhood asthma is allergic (atopic) in origin in the majority of cases, with identifiable sensitivities to dust mites, pet dander, mould and pollen. Adult-onset asthma more frequently involves non-allergic mechanisms — airway inflammation driven by occupational chemicals, obesity, infections or hormonal factors rather than IgE-mediated immune responses.

Rarely outgrown: A proportion of children with asthma experience significant improvement or apparent resolution of symptoms during adolescence. Adults almost never outgrow asthma. Once established in adulthood, asthma is typically a lifelong condition that requires ongoing management, although symptoms can often be fully controlled with appropriate treatment.

Greater risk of fixed airflow limitation: Because adult-onset asthma is often diagnosed late — after months or years of unrecognised symptoms — permanent structural changes in the airway wall may already be present. This process, called airway remodeling, results in a fixed reduction in lung function that does not fully reverse with bronchodilators. Early and accurate diagnosis is therefore particularly important in adults.

Higher burden of comorbid disease: Adults with asthma are far more likely than children to have other medical conditions that complicate management — including cardiovascular disease, hypertension, GERD, obesity, anxiety and depression. The medications used for these conditions can interact with asthma therapy in significant ways.

Recognising the Symptoms in Adults

The core symptoms of adult-onset asthma are the same as in any other form of asthma: recurrent episodes of wheezing, breathlessness, chest tightness and cough. The cough is often dry, worse at night or in the early morning, and may persist for weeks after a respiratory infection. Breathlessness may come on with activity or exposure to specific triggers, or may be present at rest in more severe cases.

The challenge is that in adults, these symptoms are routinely misattributed. Breathlessness on exertion in a middle-aged adult is often assumed to reflect cardiac disease, poor physical fitness or the natural effects of aging. A persistent cough is dismissed as a post-infectious irritation or attributed to acid reflux. Wheezing may not be noticed by the patient at all. By the time an adult receives a correct asthma diagnosis, many have spent considerable time being investigated for cardiac or other causes — or have simply been living with the symptoms without seeking care.

The key diagnostic clue in asthma — at any age — is variability. Symptoms that fluctuate in severity, that are worse at certain times of day or in certain environments, that improve with bronchodilator use, or that respond to specific identifiable triggers are the hallmarks of asthma and should prompt formal pulmonary function testing.

Diagnosis: Getting It Right

A clinical history of breathlessness and cough is not sufficient on its own to diagnose asthma. Objective lung function testing is essential, both to confirm the diagnosis and to rule out other conditions that can cause similar symptoms.

Spirometry with bronchodilator reversibility is the cornerstone of asthma diagnosis. The patient blows forcefully into a spirometer before and after inhaling a bronchodilator such as albuterol. A significant improvement in FEV1 (forced expiratory volume in one second) of 12 percent or more, combined with an absolute increase of at least 200 milliliters, confirms reversible airflow obstruction consistent with asthma.

Methacholine challenge test is used when spirometry results are normal or borderline but clinical suspicion remains high. Methacholine is inhaled in progressively increasing concentrations; the dose required to produce a 20 percent fall in FEV1 (the PC20) measures airway hyper-responsiveness. A low PC20 is strongly supportive of asthma.

Fractional exhaled nitric oxide (FeNO) testing measures eosinophilic (type 2) airway inflammation. An elevated FeNO result suggests the type of airway inflammation that responds well to inhaled corticosteroids, and can guide both initial treatment selection and monitoring of treatment response.

Allergy testing — skin prick tests or specific IgE blood tests — identifies allergic sensitivities that may be contributing to asthma even in adults. While adult-onset asthma is less often allergic in origin than childhood asthma, a significant proportion of adults do have identifiable allergen triggers, and knowing which ones enables targeted avoidance strategies.

Treatment Options for Adult-Onset Asthma

The treatment framework for adult-onset asthma follows the same stepwise approach used for asthma at any age, guided by symptom severity and the degree of lung function impairment.

Inhaled corticosteroids (ICS) are the foundation of controller therapy. Daily ICS use reduces airway inflammation, lowers bronchial reactivity and decreases the frequency and severity of attacks. Common options include fluticasone (Flovent), budesonide (Pulmicort) and beclomethasone (QVAR). Consistent daily use is essential — many patients discontinue ICS when symptoms improve, then experience a rapid deterioration.

Long-acting beta-agonists (LABAs) are added to ICS when medium-dose ICS alone does not achieve adequate control. Combination ICS/LABA inhalers such as Symbicort (budesonide/formoterol) and Advair (fluticasone/salmeterol) provide both anti-inflammatory and sustained bronchodilatory effects in a single device.

Short-acting beta-agonists (SABAs) such as albuterol remain the standard rescue medication for acute symptoms. Adults should aim to need their rescue inhaler no more than twice a week. Frequent rescue inhaler use signals that controller therapy is insufficient and requires review.

Biologic therapies are now available for adults with severe asthma who remain uncontrolled despite high-dose ICS/LABA. Options include omalizumab (Xolair) for allergic asthma, mepolizumab (Nucala) and benralizumab (Fasenra) for eosinophilic asthma, dupilumab (Dupixent) for type 2 inflammation, and tezepelumab (Tezspire) for severe uncontrolled asthma of any inflammatory subtype. These injectable antibody therapies are highly effective for selected patients and are given every two to eight weeks, typically at a specialist clinic.

Special Considerations for Adult Patients

Beta-Blockers and Cardiovascular Medications

Beta-blocker medications are among the most commonly prescribed drugs for cardiovascular disease in older adults — used to treat hypertension, angina, heart failure and some arrhythmias. Unfortunately, beta-blockers can cause significant bronchoconstriction in people with asthma by blocking the beta-2 receptors that keep the airways open. Non-selective beta-blockers such as propranolol and carvedilol carry the greatest risk. If a beta-blocker is medically necessary, a cardioselective agent such as metoprolol may be better tolerated, but close monitoring for respiratory symptoms is essential. Adults who develop new-onset asthma should inform their cardiologist and ensure that any prescribed beta-blocker is reviewed in the context of their lung condition.

Aspirin-Exacerbated Respiratory Disease (AERD)

AERD deserves particular attention in adults because the condition develops in adulthood and is frequently unrecognised. Patients typically present with a combination of asthma, chronic sinusitis and nasal polyps, and experience acute bronchospasm and nasal symptoms within 30 to 120 minutes of taking aspirin or an NSAID. The reaction can be severe and sometimes requires emergency treatment. Aspirin desensitisation — a supervised protocol in which escalating doses of aspirin are administered in a controlled clinical setting — is an effective long-term treatment for AERD in appropriate patients and can also reduce the recurrence rate of nasal polyps.

Frequently Asked Questions